ResearcherSecond Affiliated Hospital of Nanjing Medical UniversityActive in the last 2 years

Yewei Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8966-3833; OpenAlex author ID A5102005963. Sources: OpenAlex.

Their work

Papers: 6 (first author 0, last author 5)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 7

Papers, trials and grants by year

2022: 1 paper · 2023: 3 papers · 2024: 2 papers

Papers 6

Engineered extracellular vesicles for targeted reprogramming of cancer-associated fibroblasts to potentiate therapy of pancreatic cancer. Last author DOI 10.1038/s41392-024-01872-7 ↗
Targeting Reprogrammed Cancer-Associated Fibroblasts with Engineered Mesenchymal Stem Cell Extracellular Vesicles for Pancreatic Cancer Treatment. Last author DOI 10.34133/bmr.0050 ↗
Dissection of pyroptosis-related prognostic signature and CASP6-mediated regulation in pancreatic adenocarcinoma: new sights to clinical decision-making. Co-author DOI 10.1007/s10495-023-01823-7 ↗
Crosstalk of ferroptosis regulators and tumor immunity in pancreatic adenocarcinoma: novel perspective to mRNA vaccines and personalized immunotherapy. Last author DOI 10.1007/s10495-023-01868-8 ↗
RBM15 Promates the Proliferation, Migration and Invasion of Pancreatic Cancer Cell Lines. Last author DOI 10.3390/cancers15041084 ↗
Risk factors and predictive nomograms for early death of patients with pancreatic cancer liver metastasis: A large cohort study based on the SEER database and … Last author DOI 10.3389/fonc.2022.998445 ↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Hui Dong · 2 shared papers, 2023 · strength 0.41
- Paper RBM15 Promates the Proliferation, Migration and Invasion of Pancreatic Cancer Cell Lines. DOI 10.3390/cancers15041084 ↗
- Paper Crosstalk of ferroptosis regulators and tumor immunity in pancreatic adenocarcinoma: novel perspective to mRNA vaccines… DOI 10.1007/s10495-023-01868-8 ↗
Haidong Zhang · 2 shared papers, 2022–2023 · strength 0.39
- Paper RBM15 Promates the Proliferation, Migration and Invasion of Pancreatic Cancer Cell Lines. DOI 10.3390/cancers15041084 ↗
- Paper Risk factors and predictive nomograms for early death of patients with pancreatic cancer liver metastasis: A large coho… DOI 10.3389/fonc.2022.998445 ↗
Yanlong Shi · 2 shared papers, 2023 · strength 0.36
- Paper Crosstalk of ferroptosis regulators and tumor immunity in pancreatic adenocarcinoma: novel perspective to mRNA vaccines… DOI 10.1007/s10495-023-01868-8 ↗
- Paper Dissection of pyroptosis-related prognostic signature and CASP6-mediated regulation in pancreatic adenocarcinoma: new s… DOI 10.1007/s10495-023-01823-7 ↗
Pengcheng Zhou · 1 shared paper, 2024 · strength 0.28
- Paper Engineered extracellular vesicles for targeted reprogramming of cancer-associated fibroblasts to potentiate therapy of … DOI 10.1038/s41392-024-01872-7 ↗
Pengcheng Zhou · 1 shared paper, 2024 · strength 0.28
- Paper Targeting Reprogrammed Cancer-Associated Fibroblasts with Engineered Mesenchymal Stem Cell Extracellular Vesicles for P… DOI 10.34133/bmr.0050 ↗
Jun Zhu · 1 shared paper, 2023 · strength 0.17
- Paper Dissection of pyroptosis-related prognostic signature and CASP6-mediated regulation in pancreatic adenocarcinoma: new s… DOI 10.1007/s10495-023-01823-7 ↗
Fei Zhong · 1 shared paper, 2023 · strength 0.17
- Paper Dissection of pyroptosis-related prognostic signature and CASP6-mediated regulation in pancreatic adenocarcinoma: new s… DOI 10.1007/s10495-023-01823-7 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.